Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Regenerative Medicine Therapies for Rare Diseases.
Transl Sci Rare Dis. 2018 Dec 20;3(3-4):121-132. doi: 10.3233/TRD-180030.
Transl Sci Rare Dis. 2018.
PMID: 30613470
Free PMC article.
Review.
Clinical Development of Gene Therapies: The First Three Decades and Counting.
Lapteva L, Purohit-Sheth T, Serabian M, Puri RK.
Lapteva L, et al. Among authors: purohit sheth t.
Mol Ther Methods Clin Dev. 2020 Oct 10;19:387-397. doi: 10.1016/j.omtm.2020.10.004. eCollection 2020 Dec 11.
Mol Ther Methods Clin Dev. 2020.
PMID: 33209964
Free PMC article.
Review.
Item in Clipboard
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma.
Bouchkouj N, Zimmerman M, Kasamon YL, Wang C, Dai T, Xu Z, Wang X, Theoret M, Purohit-Sheth T, George B.
Bouchkouj N, et al. Among authors: purohit sheth t.
Oncologist. 2022 Jul 5;27(7):587-594. doi: 10.1093/oncolo/oyac054.
Oncologist. 2022.
PMID: 35403693
Free PMC article.
Item in Clipboard
FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
Bouchkouj N, Lin X, Wang X, Przepiorka D, Xu Z, Purohit-Sheth T, Theoret M.
Bouchkouj N, et al. Among authors: purohit sheth t.
Oncologist. 2022 Oct 1;27(10):892-899. doi: 10.1093/oncolo/oyac163.
Oncologist. 2022.
PMID: 35983953
Free PMC article.
Item in Clipboard
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.
Elmacken M, Peredo-Pinto H, Wang C, Xu Z, Tegenge M, Jaigirdar AA, Theoret MR, Purohit-Sheth T, Kasamon YL.
Elmacken M, et al. Among authors: purohit sheth t.
Clin Cancer Res. 2024 Jun 3;30(11):2309-2316. doi: 10.1158/1078-0432.CCR-23-2967.
Clin Cancer Res. 2024.
PMID: 38324398
Clinical Trial.
Item in Clipboard
FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma.
Sharma P, Kasamon YL, Lin X, Xu Z, Theoret MR, Purohit-Sheth T.
Sharma P, et al. Among authors: purohit sheth t.
Clin Cancer Res. 2023 Nov 1;29(21):4331-4337. doi: 10.1158/1078-0432.CCR-23-0568.
Clin Cancer Res. 2023.
PMID: 37405396
Free PMC article.
Item in Clipboard
Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection.
Lindblad AS, Manukyan Z, Purohit-Sheth T, Gensler G, Okwesili P, Meeker-O'Connell A, Ball L, Marler JR.
Lindblad AS, et al. Among authors: purohit sheth t.
Clin Trials. 2014 Apr;11(2):205-17. doi: 10.1177/1740774513508028. Epub 2013 Dec 2.
Clin Trials. 2014.
PMID: 24296321
Item in Clipboard
Oral allergy syndrome (pollen-food allergy syndrome).
Purohit-Sheth TS, Carr WW.
Purohit-Sheth TS, et al.
Allergy Asthma Proc. 2005 May-Jun;26(3):229-30.
Allergy Asthma Proc. 2005.
PMID: 16119040
Item in Clipboard
Cite
Cite